by Devices and Pharma | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, US-FDA
Rare Pediatric Disease Priority Review Voucher (PRV) program To expedite the review and approval of pediatric disease therapies Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro...
by Devices and Pharma | May 5, 2024 | FDA_Legislation, Industry Information, US-FDA
Navigating Complex Regulations History of Congressional Legislation for FDA Several significant congressional legislative actions have directly affected the establishment, oversight authority, and processes of the US Food and Drug Administration (FDA). As a component...
by Devices and Pharma | May 3, 2024 | Industry Information, Med-Devices, Pharmaceuticals, US-FDA
Navigating Complex Regulations Regulatory Guidance for Medical Devices & Pharmaceuticals At Medical Devices and Pharma, we specialize in providing top-tier regulatory consulting services tailored to the medical device and pharmaceutical industries. Our deep...
by Devices and Pharma | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug Exciting...
by Devices and Pharma | May 3, 2024 | Consumer Information, FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Drug Innovation - Anktiva Treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact New Drug Approval In a significant development for...
